Found: 7
Select item for more details and to access through your institution.
Mu and Delta Opioid Receptor Targeting Reduces Connexin 43-Based Heterocellular Coupling during Neuropathic Pain.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 11, p. 5864, doi. 10.3390/ijms23115864
- By:
- Publication type:
- Article
The Multimodal MOPr/DOPr Agonist LP2 Reduces Allodynia in Chronic Constriction Injured Rats by Rescue of TGF-β1 Signalling.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.749365
- By:
- Publication type:
- Article
From Plant to Chemistry: Sources of Antinociceptive Non-Opioid Active Principles for Medicinal Chemistry and Drug Design.
- Published in:
- Molecules, 2024, v. 29, n. 4, p. 815, doi. 10.3390/molecules29040815
- By:
- Publication type:
- Article
From Plant to Chemistry: Sources of Active Opioid Antinociceptive Principles for Medicinal Chemistry and Drug Design.
- Published in:
- Molecules, 2023, v. 28, n. 20, p. 7089, doi. 10.3390/molecules28207089
- By:
- Publication type:
- Article
New Insights into the Opioid Analgesic Profile of cis -(−)- N -Normetazocine-derived Ligands.
- Published in:
- Molecules, 2023, v. 28, n. 12, p. 4827, doi. 10.3390/molecules28124827
- By:
- Publication type:
- Article
Novel N -normetazocine Derivatives with Opioid Agonist/Sigma-1 Receptor Antagonist Profile as Potential Analgesics in Inflammatory Pain.
- Published in:
- Molecules, 2022, v. 27, n. 16, p. 5135, doi. 10.3390/molecules27165135
- By:
- Publication type:
- Article
Sigma-1 Receptor Inhibition Reduces Mechanical Allodynia and Modulate Neuroinflammation in Chronic Neuropathic Pain.
- Published in:
- Molecular Neurobiology, 2024, v. 61, n. 5, p. 2672, doi. 10.1007/s12035-023-03717-w
- By:
- Publication type:
- Article